Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug.
暂无分享,去创建一个
[1] B. Rumack,et al. A case of MAO inhibitor/MDMA interaction: agony after ecstasy. , 1987, Journal of toxicology. Clinical toxicology.
[2] C. Moser,et al. MDMA and human sexual function. , 1986, Journal of psychoactive drugs.
[3] S. Peroutka,et al. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[4] A. Shulgin. The background and chemistry of MDMA. , 1986, Journal of psychoactive drugs.
[5] S. Peroutka. Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA , 1990, Topics in the Neurosciences.
[6] P. Mcguire,et al. Chronic paranoid psychosis after misuse of MDMA ("ecstasy") , 1991, BMJ.
[7] J. Langston,et al. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration , 1988, Brain Research.
[8] R. Bost,et al. 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA. , 1987, JAMA.
[9] J. Riedlinger. The scheduling of MDMA: a pharmacist's perspective. , 1985, Journal of psychoactive drugs.
[10] D. Nichols,et al. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. , 1986, Journal of psychoactive drugs.
[11] C. Renfroe. MDMA on the street: Analysis Anonymous. , 1986, Journal of psychoactive drugs.
[12] D. Cooper,et al. The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. , 1988, Australian and New Zealand journal of medicine.
[13] J. Osterloh,et al. Multiple severe complications from recreational ingestion of MDMA ('Ecstasy') , 1987, JAMA.
[14] J. Newmeyer. Some considerations on the prevalence of MDMA use. , 1986, Journal of psychoactive drugs.
[15] G. Battaglia,et al. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[16] F. Leo. Psychotherapy with psychedelic drugs: a case report. , 1981 .
[17] G. Greer,et al. Subjective reports of the effects of MDMA in a clinical setting. , 1986, Journal of psychoactive drugs.
[18] G. Hayner,et al. MDMA. The dark side of ecstasy. , 1986, Journal of psychoactive drugs.
[19] R. Riemersma,et al. "Ecstasy" and sudden cardiac death. , 1988, The American journal of forensic medicine and pathology.
[20] J. Downing. The psychological and physiological effects of MDMA on normal volunteers. , 1986, Journal of psychoactive drugs.
[21] C. J. Schmidt,et al. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.
[22] G. Battaglia,et al. MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons , 1988, Pharmacology Biochemistry and Behavior.
[23] D. Sweeney,et al. ECSTACY: A Review of MDMA and MDA , 1987, International journal of psychiatry in medicine.
[24] R. K. Siegel,et al. MDMA. Nonmedical use and intoxication. , 1986, Journal of psychoactive drugs.
[25] J. Bakalar,et al. Can drugs be used to enhance the psychotherapeutic process? , 1986, American journal of psychotherapy.